Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 66, Issue 1, Pages 152-166
Publisher
Wiley
Online
2017-03-15
DOI
10.1002/hep.29156
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils
- (2016) Yanfang Liu et al. CANCER CELL
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination
- (2016) Danming Zhu et al. JOURNAL OF IMMUNOLOGY
- Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity
- (2016) Xia Li et al. NATURE IMMUNOLOGY
- Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells
- (2016) Tadaatsu Imaizumi et al. NEUROSCIENCE RESEARCH
- Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection
- (2016) Bingnan Zhang et al. Liver Cancer
- Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
- (2015) James J. Harding et al. CANCER
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Interferons and the Immunogenic Effects of Cancer Therapy
- (2015) Andy J. Minn TRENDS IN IMMUNOLOGY
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
- (2015) Benjamin Ruf et al. Molecular Therapy-Oncolytics
- Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular “pseudoinflammation” contributing to an aggressive phenotype
- (2015) Hanno Niess et al. Oncotarget
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Super-infection withStaphylococcus aureusinhibits influenza virus-induced type I IFN signalling through impaired STAT1-STAT2 dimerization
- (2014) Kathrin Warnking et al. CELLULAR MICROBIOLOGY
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma
- (2013) Jin Hou et al. CANCER CELL
- Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
- (2013) Ann-Lii Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins
- (2013) Yazan M. Abbas et al. NATURE
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
- (2011) Jin Hou et al. CANCER CELL
- IFN-Induced TPR Protein IFIT3 Potentiates Antiviral Signaling by Bridging MAVS and TBK1
- (2011) X.-Y. Liu et al. JOURNAL OF IMMUNOLOGY
- IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
- (2011) Andreas Pichlmair et al. NATURE IMMUNOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
- (2010) Ying-Chun Shen et al. JOURNAL OF HEPATOLOGY
- Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis
- (2009) S. Breitenstein et al. BRITISH JOURNAL OF SURGERY
- IFN- -Induced Apoptosis in Hepatocellular Carcinoma Involves Promyelocytic Leukemia Protein and TRAIL Independently of p53
- (2009) K. Herzer et al. CANCER RESEARCH
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway
- (2009) Christine M. Oshansky et al. VIRAL IMMUNOLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started